Melissa Soliz

speaker
262 appearances 1 recordings 1 series first heard Jun 2026 last heard 23 Jun

Melissa Soliz’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Jun OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.

Appearances

newest first · ▶ plays the moment
I'm Mel Salise and I'm very glad to be moderating today's AHLA podcast on developments in interoperability litigation.
Аби в баг, алфа
Privacy and interoperability attorney, and I lead our firm's health data interoperability and technology practice at Coppersmith Brockleman in Phoenix, Arizona.
And a significant part of my practice involves helping healthcare organizations, networks, and technology companies understand and operationalize federal interoperability requirements.
And that work spans kind of the full technology lifecycle.
We help clients design and deploy systems, we launch data governance frameworks, we draft and negotiate contracts.
And when disputes arrive we help clients navigate dispute resolution and litigation.
Our conversation today is a follow up to the AHLA webinar we did in February.
And in that webinar, we looked at what happens when disputes over health data exchange move out of the policy rooms and government processes into the courtroom.
Um and since we were all together in February, the board has really moved.
Um, a lot of cases have advanced procedurally.
Many of them have sharpened the legal theories and some have raised some really tough questions about things like network governance, data privacy, downstream uses of the data, technical access, and really the practical realities of exchanging health information.
Nationally and at scale.
So the point of today's discussion is to not turn every listener into a docket watcher like Brendan.
Um the point is really to step back.
and ask what these cases are teaching us as the healthcare community.
Uh what legal theories are gaining traction, what theories appear more fragile.
How are courts translating these information blocking concepts into these traditional litigation frameworks?
Is it working?
And most importantly, what does this all mean for providers and payers, for networks, for EHR vendors, and for the technology innovators and disruptors who are trying to make data exchange work without becoming the next cautionary tale?
Showing 1–20 of 262 · page 1 of 14 Next →